InvestorsHub Logo
Followers 0
Posts 7
Boards Moderated 0
Alias Born 01/18/2019

Re: None

Friday, 02/21/2020 6:28:11 AM

Friday, February 21, 2020 6:28:11 AM

Post# of 233065
So besides the sh***y decision to work with disgraced vyera, and a huge market cap already while on otc, leronlimab itself will almost certainly be a mega-blockbuster. Talking yearly sales at 5b-10b if first line hiv is approved, and basket trial shows superior efficacy across all 22 cancers. Any thoughts on a market cap estimate in 3 or 4 years? 30b? More?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News